SUMMARy
We investigated the influence of preoperative estimated glomerular filtration rate and postoperative acute kidney injury on outcomes after coronary bypass surgery in a local setting, with the focus on length of stay.
A retrospective analysis of prospectively collected data for 3302 consecutive patients who underwent coronary artery bypass graft surgery (June 1997 through to January 2007) at St Vincent's Public Hospital, Melbourne, was undertaken. Preoperative estimated glomerular filtration rate was calculated and categorised using US National Kidney Foundation cut-offs for chronic kidney disease (normal function; mild, moderate and severe dysfunction). Postoperative acute kidney injury was categorised using serum creatinine RIFLE criteria (no acute kidney injury, risk, injury and failure). Postoperative intensive care and hospital length of stay was determined.
The hazard ratios for time to hospital discharge up to one month decreased (indicating a longer length of stay) as severity of preoperative renal dysfunction category increased when compared to those with normal renal function: mild hazard ratio=1.02 (95% confidence interval: 0.91 to 1.15, P=0.70), moderate 0.87 (0.76 to 1.00, P=0.047), severe 0.47 (0.35 to 0.64, P <0.001). Hazard ratios also decreased as severity of postoperative acute kidney injury category increased, when compared to those with no acute kidney injury: risk 0.67 (0.58 to 0.77, P <0.001), injury 0.52 (0.41 to 0.65, P <0.001), failure 0.35 (0.20 to 0.60, P <0.001).
The increasing severity of preoperative renal dysfunction and postoperative acute kidney injury were associated with increased hospital length of stay. This has implications for resource use, informed consent and case selection.
preoperative function reduced the mortality risk for a given decline in postoperative function). In recent years the RIFLE criteria (acronym for degree of AKI: risk, injury, failure loss, endstage) 16 have been validated and used extensively to classify change in renal function in the critically ill, including cardiothoracic surgical populations 17, 18 . Therefore, the RIFLE classification of postoperative AKI in CABGS patients is more appropriate than using eGFR. Furthermore, mortality is limited as an endpoint. Hospital mortality rate -the preferred outcome measure post-CABGS for its objectivity -may have decreased so much 19 that it is no longer a useful marker of quality. As health systems focus more on cost and resource limitations, length of stay is of increasing interest as a measure of morbidity and health service utilisation. In this study we investigate whether severity of preoperative renal dysfunction (eGFR) is associated with progressively longer postoperative intensive care unit (ICU) and hospital length of stay after CABGS, and whether progressive severity of postoperative AKI, measured using the RIFLE classification, is associated with progressive increase in hospital length of stay. The study was performed in an Australian setting.
METHODS

Study population
St Vincent's Hospital, Melbourne, is a 400-bed tertiary referral hospital affiliated with the University of Melbourne with a single ICU which treats 1100 patients per year, including 500 undergoing cardiac surgery. The study was approved by the hospital's Human Research Ethics Committee and the need for informed consent was waived. Consecutive patients (3302 adults) undergoing isolated CABGS (no further surgery performed) from June 1997 to January 2007 were included. Patients who fell in one or more of the following categories were excluded: those with missing hospital length of stay data (12) , those with missing serum creatinine data (43), those undergoing regular dialysis (16) , cases performed off cardiopulmonary bypass (49) and non-isolated operations (234). The remaining sample comprised 2998 patients.
Measurement of renal function
Preoperative renal function in CABGS patients was measured using eGFR, calculated with the Modification of Diet in Renal Disease Study abbreviated equation which incorporates age, gender and serum creatinine 20 , and is endorsed by the Australasian Creatinine Consensus Working Group 21 and the US National Kidney Foundation 22 .
The African American component is superfluous in an Australian setting 21 and was not used. Serum creatinine values from which eGFR was derived were available from two data sources. Investigation of agreement between the two data sources revealed high reliability of the serum creatinine data. Preoperative eGFR was categorised using the widely used and accepted US National Kidney Foundation cut-offs for chronic kidney disease 22 :
Normal function: eGFR ≥90 ml/minute/1.73 m² Mild dysfunction: eGFR 60 to 89 ml/minute/1.73 m² Moderate dysfunction: eGFR 30 to 59 ml/minute/ 1.73 m² Severe dysfunction: eGFR <30 ml/minute/1.73 m² (dialysis excluded) Postoperative AKI was measured using the serum creatinine cutoffs of the RIFLE criteria 16 ; formulated to define and classify the severity of AKI, and extensively used and validated in critically ill populations 23, 24 . The outcome criteria of 'loss of kidney function' and 'end-stage renal failure' were not used. A patient can fulfil the RIFLE criteria through changes in serum creatinine or urine output, whichever leads to the worst classification. Urine output data were not available so patients were categorised using maximal postoperative change in serum creatinine (SCr): No AKI: <1.5 fold increase in SCr postoperatively Risk of AKI: 1.5 to 2.0 fold increase Kidney injury: >2.0 to 3.0 fold increase Failure of kidney function: >3.0 fold increase, or SCr ≥4 mg/dl with a rise ≥0.5 mg/dl
Outcome
The primary outcome was length of stay in the hospital and ICU after CABGS. Postoperative arrival time in ICU was the start time. Data used to calculate length of stay was checked against original hospital medical records for accuracy, revealing high reliability of the data. Secondary outcomes were mortality, discharge destination, time on the ventilator and haemofiltration.
Statistical analysis
Associations between the renal function exposure categories and potential confounders were investigated using the chi-squared test for categorical confounders, one-way analysis of variance for normally distributed continuous confounders, and the Kruskal-Wallis test for non-normally distributed continuous confounders. To measure associations between renal function and the outcomes, cumulative probabilities for discharge from hospital up to one month or discharge from ICU up to 14 days after CABGS, for the preoperative eGFR and the postoperative RIFLE categories, were determined using the Kaplan Meier method. Time periods of one month and 14 days were chosen a priori. The log rank test and test for trend were used to compare 'time to discharge' curves. Those who died (56 after exclusions) or whose length of stay equalled or extended beyond the cut-off points were censored. Using Cox regression, univariate analysis was performed to investigate associations between renal function variables and potential confounders, and time to discharge. Multivariate analysis was then performed with preoperative eGFR and postoperative RIFLE categories as exposures of interest, in separate analyses, to estimate the risk for prolonged length of stay after adjusting for potential confounders. The proportional hazards assumption was tested for all variables included in the final Cox regression models. Violation of the assumption was not detected. The likelihood ratio test was used to investigate whether preoperative eGFR had a modifying effect on the association between postoperative RIFLE categories and length of stay. Intercooled Stata, version 9 (Statacorp, College Station, TX, USA) was used for all analyses.
RESULTS
Study population
The study sample was predominantly male (76%) with a median age of 67 (interquartile range [IQR] 58 to 73) years. Preoperative serum creatinine levels were obtained a median of 2.5 days (IQR 1.5 to 11.5) before surgery. The median preoperative serum creatinine was 100 µmol/l (IQR 80 to 110) and median eGFR was 68.4 ml/minute/1.73 m² (IQR 57.0 to 79.5), with 30% of the study sample having significant renal dysfunction (eGFR <60 ml/minute /1.73 m² [moderate/severe categories]). Patients with more severe preoperative renal dysfunction were older, more often female, with a higher prevalence of diabetes and hypertension and higher peak postoperative serum creatinine. They also had worse left ventricular systolic function and were more likely to require inotropes in ICU ( Table 1 ). The median day on which peak postoperative creatinine levels occurred was two days (IQR one to three) after the operation. Cardiac failure was defined as a history of heart failure diagnosed by paroxysmal nocturnal dyspnoea, dyspnoea on exertion, pulmonary congestion on X-ray or being on medication for heart failure. Chronic lung disease was defined as receiving chronic bronchodilator or steroid therapy for lung disease.
Preoperative eGFR and hospital length of stay
The cumulative percentage still in hospital at seven days was 34% for those with normal renal function and increased with renal dysfunction ( Figure 1 ): mild (37%), moderate (54%) and severe (84%).
Univariate Cox regression analysis showed decreasing hazard ratios (95% confidence interval) for time to discharge up to one month across renal dysfunction categories, when compared to those with normal renal function: mild 0.90 (0.81 to 1.02, P=0.089), moderate 0.66 (0.58 to 0.75, P <0.001) and severe 0.35 (0.26 to 0.48, P <0.001). There was no significant difference between normal and mild categories. Only pre-existing factors were included in the preoperative multivariate analysis in order to provide a predictive model useful for decisionmaking. After adjusting for these potential confounders (Table 2) , hazard ratios were: mild 1.02 (0.91 to 1.15, P=0.704), moderate 0.87 (0.76 to 1.00, P=0.047) and severe 0.47 (0.35 to 0.64, P <0.001). Patients with diabetes and chronic obstructive lung disease had relative decreases in hospital discharge rates up to a month compared to those without of 17 and 28% respectively ( Table 2) . A recent acute myocardial infarction and existing cardiac failure were also associated with relative decreases in discharge rates of 17 and 27% respectively, as was increasing age.
Preoperative eGFR and ICU length of stay
Most patients were discharged from ICU within 24 hours. The cumulative percentage still in ICU at two days was 7% for those with normal renal function and increased with increasing severity of renal dysfunction: mild (8%), moderate (13%) and severe (30%). In multivariate Cox regression analysis for preoperative eGFR and ICU length of stay, we adjusted for pre-existing factors alone as potential confounders and found hazard ratios (95% confidence intervals) were: mild 0.89 (0.79 to 1.00, P=0.05), moderate 0.79 (0.69 to 0.90, P <0.001) and severe 0.46 (0.34 to 0.61, P <0.001), reflecting findings for hospital length of stay.
Postoperative AKI and hospital length of stay
The cumulative percentage still in hospital at seven days was 39% for those with no AKI and increased with kidney injury (Figure 2 ): risk of AKI (64%), kidney injury (79%) and kidney failure (95%).
In multivariate analysis pre-, intra-and postoperative variables were included. Preoperative variables remaining in the final Cox regression model with RIFLE categories for postoperative AKI (Table 3) were similar to those in the preoperative eGFR final model. The need for an intra-aortic balloon pump in the hospital stay and inotropes in ICU were associated with a 29 and 31% decrease in discharge rates up to a month, respectively. Intraoperative inotrope use had a weaker impact.
Increasing bypass time was also associated with decreasing discharge rates up to a month. After adjusting for potential confounders, hazard ratios for time to discharge up to one month compared with the 'no AKI' category were: risk of AKI 0.66 (0.57 to 0.76, P <0.001), kidney injury 0.50 (0.40 to 0.62, P <0.001) and kidney failure 0.30 (0.17 to 0.52, P <0.001). There was no statistical evidence that preoperative eGFR fiGurE 2: Time to hospital discharge for postoperative AKI categories. modified the association between postoperative AKI (RIFLE categories) and time to hospital discharge (likelihood ratio test, P interaction=0.09). Visual and statistical checks revealed no violation of the proportional hazards assumption for any of the variables in the final Cox regression models. Ventilation time and proportion of hospital deaths, discharge not to home and those requiring haemofiltration increased progressively with the severity of preoperative eGFR (Table 4 ) and postoperative AKI ( Table 5) categories.
DISCUSSION
Progressive severity of preoperative renal dysfunction measured by eGFR was associated with longer length of stay in the hospital and ICU after CABGS. Postoperative AKI (RIFLE criteria) was found to be a risk factor for prolonged hospital length of stay in all categories from 'risk' to 'failure'; this association was not modified by preoperative eGFR. Hospital mortality incidence risk, ventilation hours, requirement for postoperative haemofiltration and non-home discharges increased with poorer preoperative renal function and severity of postoperative AKI.
Our findings for preoperative eGFR are similar to those in comparable studies 5, 9 . Cooper et al (n=483,914) used the same method to categorise eGFR and found that odds for prolonged hospital length of stay increased progressively across categories from normal to severe preoperative renal dysfunction, with more notable differences between mild/moderate and moderate/severe categories 5 . Similarly, Hillis et al found that median postoperative hospital stay increased with poorer preoperative renal function (eGFR) 9 . The association between poorer renal function (eGFR) and the increased likelihood for a prolonged hospital and ICU length of stay after CABGS should be considered in case selection and when seeking informed consent from patients. Awareness of this association may also be useful in planning patient flow through ICU and cardiothoracic wards.
There are several possible reasons why progressively poorer preoperative renal function (eGFR) is associated with progressively longer length of stay. Evidence links declining kidney function with a continuous increase in cardiovascular risk 25, 26 . Consequently, preoperative eGFR may be a marker of more advanced cardiovascular disease and diminished cardiovascular reserve not detected by current clinical and investigative procedures. There is also evidence to suggest that renal dysfunction may have negative effects on distant organs other than the heart 27 , all of which could delay discharge. Alternatively, poorer renal function may directly delay clearance of anaesthetic drugs postoperatively, prolonging the need for mechanical ventilation and increasing the risk of ventilator-associated pneumonia. Renal dysfunction may also directly contribute to fluid retention, with the resulting generalised oedema impairing cerebral and respiratory function. Thus, preoperative renal dysfunction (eGFR) may be associated with prolonged length of stay either as a direct result of impaired renal function or as a marker of other subclinical organ dysfunction, either or both of which may prolong postoperative stay after CABGS.
Increasing severity of postoperative AKI was strongly associated with hospital length of stay. There are a number of possible reasons why AKI might develop after CABGS. Cardiac surgery can result in a systemic inflammatory response associated with cardiopulmonary bypass, ischaemia-reperfusion injury and global hypoperfusion 28 . This results in elevated inflammatory mediators which have been associated with increased risk of renal injury 29 . Low cardiac output, drugs, blood transfusion and use of intra-aortic balloon pump may also contribute to developing AKI post-CABGS. Some of these factors also affect the function of other organs which have their own impact on length of stay. Mechanisms through which poorer renal function may directly affect length of stay were discussed previously. Therefore, AKI may be associated with prolonged length of stay as a direct result of renal injury and as a marker of dysfunction in other organs.
The hospital mortality incidence risk over the study period in our sample after CABGS was 1.9%, similar to Cooper et al and Hillis et al, 2.5 and 3.1% (30-day) respectively. As an outcome, mortality has the advantage of objectivity. However, survival to discharge from hospital is not always an indication of full recovery. Mortality offers limited information when we consider that 17, 29 and 42% of those with mild, moderate and severe preoperative renal dysfunction respectively, are discharged to other care centres from hospital ( Table 4) ; and that those with moderate and severe renal dysfunction have a 13 and 53% relative decrease in discharge rates up to a month compared to those with normal renal function. When viewed in this context a mortality incidence risk of 2% fails to convey the risks involved. Length of stay also has limitations as an outcome. It is subject to clinician bias which could result in those with expected poor outcomes remaining in the ICU/hospital longer than clinically required; however with busy tertiary hospitals under pressure to maintain throughput and achieve surgical targets the likelihood of this occurring diminishes. As CABGS candidates become increasingly older, with more comorbidities 30 making surgery more complicated, the incorporation of information on the probability of outcomes other than mortality, into informed consent and surgical risk assessment tools may be appropriate. A prolonged hospital stay can be an arduous experience; information on risk for prolonged length of stay and 'discharge not to home' could provide a more comprehensive view of the risks for CABGS candidates and may assist in the selection of candidates for surgery.
Several studies have looked at the impact of postoperative AKI on outcomes after CABGS. Lassnigg et al 13 showed that a small increase (0 to 0.5 mg/dl) in serum creatinine postoperatively was associated with a three-fold increase in 30-day mortality, whereas a larger increase (≥0.5 mg/dl) was associated with an increase of over 18-fold in 30-day mortality. Thakar et al 15 confirmed this using percent change in eGFR relative to baseline. Postoperative percent decline in eGFR was shown to have a continuous relationship as an independent risk factor for mortality after cardiac surgery. We measured postoperative change in renal function using the RIFLE criteria which have been validated and used extensively to classify AKI in critically ill populations. The results of Thakar et al are consistent with our findings that incidence of hospital mortality increases with severity of postoperative AKI ( Table 5 ). The association of severity of postoperative AKI with adverse outcomes (Tables 3 and 5) raises the possibility that timely implementation of renal protective strategies in those at risk or displaying evidence of early AKI might improve outcomes.
It was thought that preoperative eGFR may modify the length of stay for a given degree of postoperative AKI. If this were the case, optimisation of eGFR preoperatively for those with increased risk for a prolonged length of stay could later be evaluated for its impact on outcomes. Thakar et al 15 studied the modifying effect of preoperative eGFR on the association between postoperative percent decline in eGFR and mortality in 31,677 cardiac surgical patients. A better preoperative eGFR was found to attenuate the effect of postoperative decline in eGFR on mortality. Contrary to their findings, we did not observe a modifying effect of preoperative eGFR on the association between severity of postoperative AKI and hospital length of stay. This may be due to our smaller sample size; Thakar et al had a larger study (n=31,667) increasing the statistical power to detect a modifying effect. Alternatively, using length of stay as our primary outcome, rather than mortality, might explain the lack of interaction. Further investigation using mortality as the outcome in logistic regressions again observed no interaction between preoperative eGFR and severity of postoperative AKI. Notably, the statistical power for this interaction was limited since there were only 56 deaths in our study sample. Moreover, logistic regressions with AKI as a dependent variable against preoperative eGFR found no meaningful association.
LIMITATIONS
Although the data were collected prospectively as part of routine data collection from 1997 to 2007, this is a retrospective analysis and therefore control over quality of the data was limited and there may be potential confounders unaccounted for, however data from which the outcome (length of stay) and exposures (preoperative eGFR/postoperative AKI) were derived were shown to be accurate and reliable. For RIFLE classification, urine output data were not available so patients were categorised using serum creatinine criteria alone.
The Modification of Diet in Renal Disease equation tends to underestimate GFR in those with normal renal function (eGFR ≥90) 31 . This could lead to misclassification and decreased effect size in the mild category, resulting in less differentiation between mild and normal categories. There may also have been some patients where eGFR did not represent actual GFR due to its decreased reliability in the non-steady state, which may have lead to non-differential misclassification and reduced effect size. Nonetheless, eGFR is becoming increasingly accepted as a measure of preoperative renal function in this population 5, 9, 17, 18 .
Not all drugs that affect kidney function could be taken into account.
We have calculated eGFR using the equation previously recommended 21 in which the serum creatinine component is multiplied by 186. This equation has since been changed 32 due to discrepancies between the assay used to establish the formula and those now produced to standardised recommendations, and the serum creatinine component will now be multiplied by 175. The data were re-analysed using the newly modified formula and our findings were unchanged.
CONCLUSION
Progressive severity of preoperative renal dysfunction (eGFR) was associated with longer lengths of stay in hospital and ICU after CABGS. The incorporation of information on the risk for prolonged length of stay and 'non-home discharge' after CABGS into the informed consent process and surgical risk assessment tools could provide a more comprehensive view of the surgical risks for CABGS candidates.
Increasing severity of RIFLE categories for postoperative AKI were strongly associated with prolonged length of stay indicating that the timely implementation of renal protective strategies in those at high risk or displaying evidence of early renal dysfunction may provide benefit. Further research into earlier biomarkers of AKI and interventions to prevent or ameliorate postoperative renal deterioration is required.
